Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 9Phase 3 3Phase 1/2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 5Gastrointestinal 5Gynecologic 4Breast 3Thoracic 2Dermatologic 2Sarcoma 1Other neoplasm 1CNS 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

pembrolizumab 120Carboplatin 114Pemetrexed 74Cisplatin 71Nivolumab 68Paclitaxel 58Docetaxel 56Radiotherapy 41Erlotinib Hydrochloride 41Gemcitabine 35Etoposide 34atezolizumab 30osimertinib 29Cetuximab 27Ipilimumab 25Bevacizumab 25Radiosurgery 22durvalumab 21Cyclophosphamide 20Drug Therapy 18130-nm albumin-bound paclitaxel 17avelumab 14Taxes 14Gefitinib 14Albumin-Bound Paclitaxel 14Irinotecan 13Injections 13fludarabine 11Radiation 11cemiplimab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Celecoxib × Thoracic × Clear all
NCT00046839 2015-11-17

Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 1/2 Completed
21 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00073866 2012-07-19

Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Northwestern University

Phase 1/2 Completed
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡